On June 4 2025, Elsevier officially released the 2024 CiteScore, a key metric used to assess the impact of academic journals. VIEW, jointly sponsored by China Professional Community of Experimental Medicine (CPCEM) and published by John Wiley & Sons, achieved a CiteScore of 14.5 for 2024. This marks a continued upward trend from its 2023 score of 12.6, placing VIEW among the top journals in the fields of materials and engineering science.

The 22nd China International In Vitro Diagnostics Expo by CACLP and the 5th China IVD Supply Chain Expo (CISCE) took place from 22–24 March 2025 in Hangzhou, achieving unprecedented scale and impact. CACLP 2025 attra..

From 18-22 May 2025, Brussels, Belgium, hosted the 26th IFCC-EFLM EUROMEDLAB Congress of Clinical Chemistry and Laboratory Medicine and the 49th Annual Meeting of the Royal Belgian Society of Laboratory Medicine. ..

With just two weeks to go, anticipation is building for the 22nd China International In Vitro Diagnostic Expo by CACLP, the largest and most influential gathering of the IVD industry in China! Taking place 22-24 March..

The number of foreigners coming to China has increased significantly in the first quarter of this year as a result of the continued improvement in the country's policies to facilitate cross-border travel, the National Immigration Administration said on Tuesday.

On November 22, 2024, to further facilitate cross-border travel, China decided to include more countries in its visa waiver program and extend the visa-free policy to ordinary passport holders from Bulgaria, Romania, Croatia, Montenegro, North Macedonia, Malta, Estonia, Latvia and Japan on a trial basis from November 30, 2024 to December 31, 2025. 

It is stated that from 30 August 2023, all travelers entering China will no longer need to undergo any COVID-19 testing.

From March 15, China has officially announced the resumption of all kinds of visas, including tourist visas (L Visa), and visa-free policies have been reinstated.